JPS61152614A - Whitening cosmetic - Google Patents

Whitening cosmetic

Info

Publication number
JPS61152614A
JPS61152614A JP27974284A JP27974284A JPS61152614A JP S61152614 A JPS61152614 A JP S61152614A JP 27974284 A JP27974284 A JP 27974284A JP 27974284 A JP27974284 A JP 27974284A JP S61152614 A JPS61152614 A JP S61152614A
Authority
JP
Japan
Prior art keywords
liver
water
cosmetic
extract
bird
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP27974284A
Other languages
Japanese (ja)
Other versions
JPH0512324B2 (en
Inventor
Yoshitaka Higa
良喬 比嘉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Priority to JP27974284A priority Critical patent/JPS61152614A/en
Publication of JPS61152614A publication Critical patent/JPS61152614A/en
Publication of JPH0512324B2 publication Critical patent/JPH0512324B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird

Abstract

PURPOSE:A novel safe whitening cosmetic having improved whitening effect and antisuntan effect, obtained by blending a cosmetic base with a water extract of liver of mammal or bird. CONSTITUTION:For example, liver for mammal such as bovine, swine, sheep, goat, etc., or liver of bird such as chicken, etc., is washed with water and blood is removed from its. The liver is then ground into a gruel state, blended with 2-3 times as much as water, stirred, protein removal operation is carried out, the resultant material is filtered to give an extracted essence. 0.01-10.0wt% of the essence is added to a cosmetic base useful for toilet lotion, cream, milky lotion, pack, etc, or an auxiliary, to give a cosmetic. The extracted essence has improved inhibitory action on melanin dyestuff formation.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は化粧料、ことに色白化粧料に関するものである
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to cosmetics, particularly fair skin cosmetics.

〔従来の技術〕[Conventional technology]

従来、色白化粧料としては、過酸化水素、過酸化亜鉛、
過酸化マグネシウム、過酸化す) IJウム。
Traditionally, skin-lightening cosmetics include hydrogen peroxide, zinc peroxide,
Magnesium peroxide, peroxide) IJum.

過硼酸亜鉛、過硼酸マグネシウム、過硼酸ナトリウムな
どの過酸化物を配合した化粧料、あるいは蒼鉛剤または
水銀剤などが使われていたが、前者の過酸化物はきわめ
て不安定な物質であるため、化粧料への配合、保存など
に難点があり、またその色白効果も十分であるとはいえ
ながった。近年、ビタミンC,システィン、コロイド硫
黄などを配合する化粧料もあるが、なお十分な効果が期
待できない。
Cosmetics containing peroxides such as zinc perborate, magnesium perborate, and sodium perborate, or agents such as blue lead or mercury were used, but the former peroxide is an extremely unstable substance. However, it has been difficult to incorporate into cosmetics, store, etc., and its skin whitening effect has not been satisfactory. In recent years, there are cosmetics that contain vitamin C, cysteine, colloidal sulfur, etc., but they are still not expected to have sufficient effects.

さらに、本発明者らは先にコウジ酸を含有する化粧料(
特公昭56−18569号公報)、コウジ酸の誘導体を
含有する化粧料(特開昭56−79616号。
Furthermore, the present inventors have previously discovered cosmetics containing kojic acid (
Japanese Patent Publication No. 56-18569), cosmetics containing derivatives of kojic acid (Japanese Patent Publication No. 56-79616).

特開昭56−7710号公報)、クエルセチンの脂肪酸
エステルを含有する化粧料(特開昭58−131911
号公@)、エルゴチオネインを含有する化粧料(特公昭
55−27883号公報)を開示した。
JP-A-56-7710), cosmetics containing quercetin fatty acid ester (JP-A-58-131911)
(Japanese Patent Publication No. 55-27883) disclosed a cosmetic containing ergothioneine.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

本発明は公知の色白化粧料の有効成分と異なる安全かつ
有効な色白効果を有する成分について研究した結果、哺
乳動物や鳥類の肝臓水抽出物がすぐれたメラニン色素生
成抑制作用があることを見い出し、この成分を含有せし
めることによって色白効果、日焼止め効果がすぐれ、し
かも安全な新規色白化粧料を提供することを目的とする
ものである。
As a result of research into ingredients that have a safe and effective skin-whitening effect that are different from the active ingredients of known skin-whitening cosmetics, the present invention discovered that mammalian and bird liver water extracts have an excellent melanin pigment production inhibiting effect. The object of the present invention is to provide a novel skin-whitening cosmetic that has excellent skin-whitening effects and sunscreen effects by containing this component, and is also safe.

〔問題点を解決するための手段〕[Means for solving problems]

本発明は哺乳動物や鳥類の肝臓の水抽出物を化粧料基剤
に配合した色白効果のすぐれたしかも安全件の高い色白
化粧料である。
The present invention is a skin-lightening cosmetic that has an excellent skin-whitening effect and is highly safe, which contains a water extract of mammalian or bird liver as a cosmetic base.

本発明の有効成分は哺乳動物又は鳥類の肝臓からの水溶
性エキスであり、一般の抽出法により得られる0例えば
肝臓としては、牛、豚、羊、山羊などの哺乳動物の肝臓
、ニワトリなどの鳥類の肝臓等いずれも利用できる。抽
出は肝臓を水洗除血したのち磨砕してカニ状となし2〜
3倍量の水を加えて数時間攪拌したのち除蛋白操作を行
い、濾過工程を経て、抽出エキスを得ることができる。
The active ingredient of the present invention is a water-soluble extract from the liver of a mammal or bird, which can be obtained by a general extraction method. Any bird liver can be used. For extraction, the liver is washed with water to remove blood, then ground into crab-shaped pieces 2~
After adding three times the amount of water and stirring for several hours, a protein removal operation is performed, and an extracted extract can be obtained through a filtration process.

次に本発明の有効成分である肝臓エキスの製造例をあげ
る。
Next, an example of the production of liver extract, which is the active ingredient of the present invention, will be given.

製造例1 豚の肝臓1 kgを磨砕し、21の水を加えて3時間攪
拌抽出を行ったのち、乳酸を加えてpHを4.5前後に
調整し、温度を80℃以上に加熱し、蛋白を変性せしめ
て、組織層と一緒に濾別し、濾液は更に硅凍土を用いて
濾過を行い抽出エキス2.51を得た。得られた抽出物
は比重1.003〜1,008 、pH4,5〜5.5
、蒸発残留物2.0 g / Loosen以下、全窒
素90〜150 mg/ 100+sj!、ニトロプル
シド反応、ジアゾ反応は共に陽性である。
Production Example 1 1 kg of pig liver was ground, water was added from No. 21, and extraction was performed with stirring for 3 hours. Lactic acid was added to adjust the pH to around 4.5, and the temperature was heated to 80°C or higher. The protein was denatured and filtered together with the tissue layer, and the filtrate was further filtered using diatomaceous earth to obtain extract 2.51. The obtained extract has a specific gravity of 1.003-1,008 and a pH of 4.5-5.5.
, evaporation residue below 2.0 g/Loosen, total nitrogen 90-150 mg/100+sj! , nitroprusside reaction, and diazo reaction are both positive.

製造例2 ニワトリの肝1110kgに精製水201を加え、ミキ
サー等で組織をつぶし80〜90°Cで3時間攪拌抽出
する。次に10%硫酸でpHを4.5に調整して蛋白竺
Production Example 2 Purified water 201 kg was added to 1110 kg of chicken liver, the tissue was crushed using a mixer, etc., and the mixture was stirred and extracted at 80 to 90°C for 3 hours. Next, adjust the pH to 4.5 with 10% sulfuric acid and prepare the protein powder.

組織片を布等で濾過して除去する。更に微小粒子は遠心
分離によるか又はセライト等で濾過して抽出液を得る。
Remove tissue pieces by filtering with a cloth or the like. Furthermore, the microparticles are centrifuged or filtered through Celite or the like to obtain an extract.

次にp)Iを2.0に調整し50℃前後に加温したもの
に酸化第1銅20 gを徐々に加えて2〜3分間ゆるく
攪拌すると、アミノ酸等の銅塩が析出してくるのでこれ
を遠心分離して採取する。この銅塩を冷精製水で数回洗
滌し、52の精製水に懸濁させたものに硫化水素ガスを
吹込み、銅を硫化銅として沈澱させる。濾紙で濾過した
液は容量が115位になるまで減圧濃縮すると過剰の硫
化水素が除去できる。この抽出液は普通は最終的に20
1に調整して化粧料に使用される。
Next, after adjusting p)I to 2.0 and heating it to around 50°C, gradually add 20 g of cuprous oxide and stir gently for 2 to 3 minutes, and copper salts such as amino acids will precipitate out. So, collect it by centrifuging it. This copper salt is washed several times with cold purified water, and hydrogen sulfide gas is blown into the suspension in the purified water of step 52 to precipitate copper as copper sulfide. Excess hydrogen sulfide can be removed by concentrating the liquid filtered through a filter paper under reduced pressure until the volume reaches 115 degrees. This extract usually has a final content of 20
It is adjusted to 1 and used in cosmetics.

本発明の色白化粧料は主として化粧水、クリーム、乳液
、パックなどの皮膚化粧料であり、それらの各化粧料に
通常に使用される化粧基剤、助剤などに上記肝臓抽出エ
キスを0.01〜10.0%加えて化粧料とする。
The skin fairing cosmetics of the present invention are mainly skin cosmetics such as lotions, creams, milky lotions, and packs, and 0.0% of the above-mentioned liver extract is added to the cosmetic bases and auxiliaries commonly used in these cosmetics. Add 01 to 10.0% to make cosmetics.

例えは、化粧水においては、精製水にグリセリン、プロ
ピレングリコールなどの保湿剤、皮膚栄養剤などを熔解
し、防腐剤、香料などをアルコールに溶解し、両者を混
合して室温下に可溶化する一般の化粧水の製造において
、水溶部又はアルコール部に本発明の有効成分である肝
臓抽出エキスを0.01〜10.0%になるように加え
て化粧水とする。
For example, in lotion, moisturizers such as glycerin and propylene glycol, skin nutrients, etc. are dissolved in purified water, preservatives, fragrances, etc. are dissolved in alcohol, and the two are mixed and solubilized at room temperature. In the production of a general lotion, a liver extract, which is the active ingredient of the present invention, is added to the water-soluble part or the alcohol part at a concentration of 0.01 to 10.0% to form a lotion.

クリームにおいては、精製水に親水性成分例えばグリセ
リン、ソルビットなどの保湿剤を添加して水相部とし、
油相部はミツロウ、パラフィン。
In creams, hydrophilic ingredients such as humectants such as glycerin and sorbitol are added to purified water to form the aqueous phase.
The oil phase is beeswax and paraffin.

マイクロクリスタリンワックス、セレシン、高級脂肪酸
、硬化油などの固形油分、ワセリン、ラノリン、グリセ
リドなどの半固形油分、それにスクワラン、流動パラフ
ィン、各種エステル油などの液状油分に防腐剤、界面活
性剤などの油性成分を添加し調整する。このようにして
得られた水相部を加温して、ゆるやかに攪拌しつつ同温
度に加温された油相部を徐々に添加して乳化してクリー
ムとする一般のクリームの製造において、水相部に本発
明の有効成分である肝臓抽出エキスを0.01〜IO0
θ%になるように加えてクリームとする。
Solid oils such as microcrystalline wax, ceresin, higher fatty acids, and hydrogenated oils; semi-solid oils such as vaseline, lanolin, and glycerides; liquid oils such as squalane, liquid paraffin, and various ester oils; and oil-based oils such as preservatives and surfactants. Add and adjust ingredients. In the production of general cream, the aqueous phase obtained in this way is heated, and the oil phase heated to the same temperature is gradually added while gently stirring to emulsify the cream. Liver extract, which is the active ingredient of the present invention, is added to the aqueous phase from 0.01 to IO0.
Add to make a cream by adding it to θ%.

乳液においては、精製水にグリセリンなどの保湿剤、酸
又はアルカリのPH1l!i整剤などを加え加熱混合し
てエタノールを加え水相部とし、ミツロウ、パラフィン
などの固形油分、ワセリン、ラノリンなどの半固形油分
、スクワラン、流動パラフィン、各種エステル油などの
液状油分に、防腐剤。
For emulsions, use purified water, moisturizers such as glycerin, and acid or alkaline pH 1L! Add preservatives, etc., heat and mix, add ethanol to make the aqueous phase, and add preservatives to solid oils such as beeswax and paraffin, semi-solid oils such as vaseline and lanolin, liquid oils such as squalane, liquid paraffin, and various ester oils. agent.

界面活性剤などの油性成分を添加調整して混合加熱し油
相部とし、油相部を水相部に加えて予備乳化を行い、こ
れにカルボキシビニルポリマー、カルボキシメチルセル
ロースなどの保護コロイド剤を加え、ホモミキサーで均
一に乳化して乳液とする一般の乳液の製造において、水
相部に本発明の有効成分である肝臓抽出エキ′スを0.
01〜10.0%になるように水相部に加えて乳液とす
る。
Add and adjust oily components such as surfactants, mix and heat to form an oil phase, add the oil phase to the aqueous phase to pre-emulsify, and add protective colloids such as carboxyvinyl polymer and carboxymethylcellulose. In the production of a general emulsion, which is uniformly emulsified using a homomixer to form an emulsion, 0.0% of the liver extract, which is the active ingredient of the present invention, is added to the aqueous phase.
01 to 10.0% to the aqueous phase to form a milky lotion.

パックにおいては、精製水にグリセリンなどの保湿剤、
ポリビニルアルコール、ビーガムなどの皮膜剤などを加
えて膨潤させ、これに必要があればカオリン、タルク、
酸化亜鉛などの粉末を加え、香料、防腐剤などを溶解し
たエタノールを加えてペースト状となるまで混練する一
般のパックの製造において、本発明の有効成分である肝
臓抽出エキスを0.01〜10.0%になるように加え
てパックとする。
The pack contains purified water, moisturizers such as glycerin,
Swell by adding a coating agent such as polyvinyl alcohol or vegum, and add kaolin, talc, etc. if necessary.
In the production of general packs, in which powder such as zinc oxide is added, ethanol in which fragrances, preservatives, etc. are dissolved, and kneaded until it becomes a paste, the liver extract, which is the active ingredient of the present invention, is added at a concentration of 0.01 to 10%. Add it to .0% and make it into a pack.

次に本発明の実施例をあげる。Next, examples of the present invention will be given.

〔実施例〕〔Example〕

実施例工 化粧水 肝臓抽出エキス(1i1造例2により得たもの)5重置
% クエン酸            0.4 #炭酸カル
シウム         o、2〃プロピレングリコー
ル      9 〃エタノール          
 5 #水                  79
.4  #香料及び防腐剤         適量実施
例2 コールドクリーム 肝臓抽出エキス(製造例2により得たもの)1重量% ミツロウ            10〃セレシン  
          7 〃色白ワセリン      
     4 “ラノリン             
4 〃ミリスチン酸イソプロピル     4 〃流動
パラフィン         44〃スクワラン   
        4 〃ポリオキシエチレンセチルエー
テル 3 〃 プロピレングリコール      2 〃乳化剤   
         263〃水           
        14〃香料            
  適量実施例3 パンク 肝臓抽出エキス(製造例2により得たもの)0.3重量
% ビーガム            5 〃スクワラン 
          2 〃プロピレングリコール  
    5 〃酸化亜鉛            10
〃カオリン            10〃エタノール
           5 〃香料及び防腐剤    
     適量精製水            62.
2  〃〔発明の効果〕 本発明の有効成分である哺乳動物、鳥類の肝臓水抽出物
のチロシナーゼ抑制作用は下記の通りである。
Example Industrial Lotion Liver Extract (obtained according to 1i1 Preparation Example 2) 5% citric acid 0.4 #Calcium carbonate o, 2 Propylene glycol 9 Ethanol
5 #Wed 79
.. 4 #Fragrance and preservative appropriate amount Example 2 Cold cream liver extract (obtained according to Production Example 2) 1% by weight Beeswax 10 Ceresin
7 Fair-skinned Vaseline
4 “Lanolin
4 Isopropyl myristate 4 Liquid paraffin 44 Squalane
4 Polyoxyethylene cetyl ether 3 Propylene glycol 2 Emulsifier
263 water
14.Fragrance
Appropriate amount Example 3 Punk liver extract (obtained according to Production Example 2) 0.3% by weight Veegum 5 Squalane
2 〃Propylene glycol
5 Zinc oxide 10
〃Kaolin 10〃Ethanol 5〃Fragrances and preservatives
Appropriate amount of purified water 62.
2 [Effects of the Invention] The tyrosinase-inhibiting action of the mammalian and avian liver water extract, which is the active ingredient of the present invention, is as follows.

実験例 マツキルベイン緩衝液pH6,8(Mcllvain 
Buffer )0.9mj!、 L−チロシン111
1に試料1a+j!を加えた液を3分間インキュベート
した後、マツシュルームチロシナーゼ0,1mJを加え
て更にインキュベートし1分毎に生成されるドーパクロ
ム(最大吸収波長475n鵬)を測定した。
Experimental example Pine kilvain buffer pH 6,8 (Mcllvain
Buffer)0.9mj! , L-tyrosine 111
Sample 1a+j in 1! After incubating the solution for 3 minutes, 0.1 mJ of pine mushroom tyrosinase was added and further incubated, and dopachrome (maximum absorption wavelength 475 nm) produced every minute was measured.

試料としては、製造例2で得られた本発明の有効成分の
2.5w/v%、6.25 w/ v%、12.5w/
v%の含有液を用い、対照には水を用いた。
The samples were 2.5 w/v%, 6.25 w/v%, and 12.5 w/v% of the active ingredient of the present invention obtained in Production Example 2.
A solution containing v% was used, and water was used as a control.

以上の測定の結果を添付図面で示す。The results of the above measurements are shown in the attached drawings.

この図面で明らかな如(、本発明の有効成分はすぐれた
チロシナーゼ抑制作用を示した。
As is clear from this figure, the active ingredient of the present invention exhibited an excellent tyrosinase inhibitory effect.

【図面の簡単な説明】[Brief explanation of drawings]

図面は本発明の有効成分のドーパクロム生成を示す。 図中、−〇−は有効成分2.5w/v%含有液、−×−
は同6.25賀/V%含有液、−1−は同12.5 w
/V%含有液のドーパクロム生成を示す。−〇−は対照
である水のドーパクロム生成を示す。
The figure shows the dopachrome production of the active ingredient of the invention. In the figure, -〇- is a liquid containing 2.5 w/v% of the active ingredient, -×-
is the same 6.25w/V% containing liquid, -1- is the same 12.5w
/V%-containing liquid shows dopachrome production. -〇- indicates dopachrome production in water, which is a control.

Claims (1)

【特許請求の範囲】[Claims] 1、哺乳動物、鳥類の肝臓水抽出物を化粧料基剤に配合
することを特徴とする色白化粧料。
1. A fair-skinned cosmetic characterized by incorporating a mammalian or bird liver water extract into a cosmetic base.
JP27974284A 1984-12-27 1984-12-27 Whitening cosmetic Granted JPS61152614A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27974284A JPS61152614A (en) 1984-12-27 1984-12-27 Whitening cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27974284A JPS61152614A (en) 1984-12-27 1984-12-27 Whitening cosmetic

Publications (2)

Publication Number Publication Date
JPS61152614A true JPS61152614A (en) 1986-07-11
JPH0512324B2 JPH0512324B2 (en) 1993-02-17

Family

ID=17615260

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27974284A Granted JPS61152614A (en) 1984-12-27 1984-12-27 Whitening cosmetic

Country Status (1)

Country Link
JP (1) JPS61152614A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS638313A (en) * 1986-06-27 1988-01-14 Sansho Seiyaku Kk Drug capable of inhibiting melanization for external use
EP0588498A2 (en) * 1992-09-16 1994-03-23 Kraft Foods, Inc. Topical compositions for protection against ultraviolet radiation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6064909A (en) * 1983-09-20 1985-04-13 Shiseido Co Ltd Cosmetic

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6064909A (en) * 1983-09-20 1985-04-13 Shiseido Co Ltd Cosmetic

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS638313A (en) * 1986-06-27 1988-01-14 Sansho Seiyaku Kk Drug capable of inhibiting melanization for external use
EP0588498A2 (en) * 1992-09-16 1994-03-23 Kraft Foods, Inc. Topical compositions for protection against ultraviolet radiation
EP0588498A3 (en) * 1992-09-16 1994-10-05 Gen Foods Inc Topical compositions for protection against ultraviolet radiation.

Also Published As

Publication number Publication date
JPH0512324B2 (en) 1993-02-17

Similar Documents

Publication Publication Date Title
KR920003328B1 (en) Whitening cosmetic composition
JP3135943B2 (en) Whitening agent
JPH0725742A (en) Fair-skinning cosmetic
JPS6061513A (en) Cosmetic
JPH0545569B2 (en)
JPH07187988A (en) Melanism inhibitor, its production and skin-beautifying containing the same cosmetic
JP3000224B2 (en) Skin cosmetics
JPH06271452A (en) Skin cosmetic containing extract of plant of cactuses
JP2001122733A (en) Catalase production-promoting preparation and skin preparation for external use containing the same
JPH0532556A (en) Skin agent for external use
JPS61152614A (en) Whitening cosmetic
JPH1171234A (en) Skin preparation for external use
JP3055826B2 (en) Skin cosmetics
KR920003324B1 (en) Whitening cosmetics
JP2000510165A (en) Combination of Phenol Derivatives with Iridaceae Extract for Depigmentation of Skin and Body Growth and Compositions Containing It
JPH0873370A (en) Composition for make-up or dermatology containing plant extract in capsule
JP2006137705A (en) Melanogenesis inhibitor and skin care preparation for external use
JPH11180854A (en) Skin preparation for external use
JP3224962B2 (en) External preparation for skin
KR870001430B1 (en) Cosmetic composition for skin
JPH03127712A (en) Agent for external application
JP2000302657A (en) Cosmetic composition for suppressing senile process of skin
JPH0812522A (en) Melanogenesis inhibitor and skin external preparation
JPH10203922A (en) Cosmetic
JP2610310B2 (en) External preparation